|The more we know about rare diseases, the more likely we are to find safe and ...|
Recently The National Organization for Rare Diseases (NORD), has teamed up with the patient advocacy group that represents people with the rare disease known as Von Hippel Lindau disease. This is a condition with many debilitating symptoms that also ...
FDA.gov (blog) - Thu, 23 Oct 2014 08:00
|Telomere shortening may cause genetic anticipation in VHL syndrome|
... Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) (Wong et al., 2014), and more recently a study suggests that this phenomenon is also seen in another hereditary kidney cancer syndrome, Von Hippel-Lindau syndrome (VHL) (Ning et al., 2014).
ScienceBlog.com (blog) - Thu, 25 Sep 2014 23:56
|Rini Discusses Variable Impact of Angiogenesis in Solid Tumors|
For instance, my specialty of RCC appears especially suitable given that the underlying biology of RCC (von Hippel-Lindau gene mutation) leads to an addition to the vascular endothelial growth factor (VEGF) pathway. ... The biggest limitation is a ...
OncLive - Mon, 13 Oct 2014 06:53
|Somatic Mutations in the ATRX Gene Reported for the First Time in ...|
For expression analysis, they are divided into cluster 1 tumors, which are the succinate dehydrogenase inherited (SDHx) susceptibility mutation and von Hippel–Lindau (VHL). Cluster 2 represents the RET/NF1 TMEM127/MAX–associated tumors. Sporadic tumors ...
OncLive - Mon, 13 Oct 2014 09:18
|Surviving one day at a time: Officer Brian McCamis said he is thankful for ...|
19 Lifestyles section, was born with Von Hippel-Lindau syndrome, or VHL, a rare genetic disorder characterized by the formation of tumors that strikes 1 in 36,000 individuals. The tumors grow in different parts of the body — the brain, retina, kidneys ...
Cleveland Daily Banner - Sun, 28 Sep 2014 09:52
|VHL Alliance Funds Harvard/Tel Aviv Universities Cancer Research|
Both researchers will screen and study potential therapeutic agents to prevent tumor development as occurs in von-Hippel Lindau syndrome and other forms of cancer. With the VHL Alliance funding, Dr. Iliopoulos will create a novel method to screen ...
PR Web (press release) - Thu, 25 Sep 2014 00:05
|유전성 암환자 iPS세포 제작 성공|
희귀 유전성 질환인 폰 히펠-린다우씨병(Von hippel lindau syndrome:VHL) 환자로부터 채취한 세포를 이용해 인공다능성줄기세포(iPS세포)를 제작하는 실험이 성공했다. 일본 교토대 의학연구과 나카무라 에이지로 준교수를 비롯한 연구팀은 지난주 요코하마시에서 ...
디지틀보사 - Mon, 29 Sep 2014 13:48